Daria Hazuda
About Daria Hazuda
Daria Hazuda is the Head of Infectious Disease and Vaccines Research, known for her leadership at Merck, where she has significantly contributed to the development of antivirals and vaccines.
Title at Current Company
Daria Hazuda currently holds the title of Head of Infectious Disease and Vaccines Research. In this role, she is responsible for overseeing research and development projects aimed at combatting various infectious diseases and developing vaccines.
Previous Roles at Merck
Prior to her current position, Daria Hazuda served as the vice president of infectious disease and vaccines and chief scientific officer at the Merck Cambridge Research site. She has held various roles at Merck, where she managed cross-functional research teams working on antibiotic, antiviral, and vaccine research, as well as neuroscience discovery and innovative platform development.
Drug Development and Research Contributions
Daria Hazuda has led teams responsible for discovering and developing multiple drugs that have received approval. Her work includes the development of antivirals for HIV, hepatitis C, and cytomegalovirus, as well as antibacterial treatments. She directed the research efforts that led to the identification of the first-in-class HIV integrase inhibitor, a breakthrough that won the 2008 Prix Galien award.
Awards and Publications
Throughout her career, Daria Hazuda has received numerous awards in recognition of her contributions to science and medicine. She has also made significant academic contributions, authoring over 200 peer-reviewed publications.
Education and Training
Daria Hazuda trained as a biochemist at the State University of New York at Stony Brook. She furthered her expertise with a postdoctoral research fellowship in the department of immunology at Smith Kline, which is now known as GSK.